As global markets face volatility, particularly in the technology sector, Asian markets have shown resilience with Chinese indices reaching new highs amid easing trade tensions. In this environment, growth companies with high insider ownership can be appealing as they often indicate strong confidence from those who know the business best and may offer stability amidst broader market fluctuations.
Name
Insider Ownership
Earnings Growth
Streamax Technology (SZSE:002970)
32.5%
33.1%
Seers Technology (KOSDAQ:A458870)
33.9%
84.6%
Novoray (SHSE:688300)
23.6%
31.4%
M31 Technology (TPEX:6643)
26.3%
117.3%
Loadstar Capital K.K (TSE:3482)
31%
23.6%
Laopu Gold (SEHK:6181)
34.8%
34.3%
J&V Energy Technology (TWSE:6869)
17.5%
24.9%
Gold Circuit Electronics (TWSE:2368)
31.4%
35.2%
Fulin Precision (SZSE:300432)
11.6%
55.2%
Ascentage Pharma Group International (SEHK:6855)
12.8%
56.2%
Click here to see the full list of 627 stocks from our Fast Growing Asian Companies With High Insider Ownership screener.
We’ll examine a selection from our screener results.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Beijing Fourth Paradigm Technology Co., Ltd. is an investment holding company offering platform-centric artificial intelligence solutions in China, with a market cap of HK$27.53 billion.
Operations: The company’s revenue is primarily derived from three segments: Sagegpt Aigs Services (CN¥505.70 million), 4ParadigmSage AI Platform (CN¥4.57 billion), and Shift Intelligent Solutions (CN¥940.30 million).
Insider Ownership: 20.5%
Earnings Growth Forecast: 110.3% p.a.
Beijing Fourth Paradigm Technology has shown significant revenue growth, with a 26.7% annual forecast surpassing the Hong Kong market’s average. Recent partnerships, like its strategic alliance with Solowin Holdings for blockchain compliance solutions, highlight its innovative edge. Despite a net loss reduction to CNY 66.97 million and a follow-on equity offering raising HK$1.31 billion, insider ownership remains high without substantial recent buying or selling activity reported in the last three months.
SEHK:6682 Ownership Breakdown as at Nov 2025
Simply Wall St Growth Rating: ★★★★★☆
Overview: InnoCare Pharma Limited is a biopharmaceutical company focused on discovering, developing, and commercializing drugs for cancer and autoimmune diseases in China, with a market cap of HK$28.93 billion.
Operations: The company generates revenue primarily from its pharmaceuticals segment, amounting to CN¥1.32 billion.
Insider Ownership: 21.7%
Earnings Growth Forecast: 99.6% p.a.
InnoCare Pharma is poised for substantial growth, with revenue expected to increase by 22.8% annually, outpacing the Hong Kong market. Despite a recent net loss of CNY 64.41 million, the company has reduced its losses significantly from last year and continues to innovate in oncology treatments like ICP-B794 and zurletrectinib. While insider ownership remains high, there has been significant insider selling recently. The stock trades at a discount of 28.7% below its estimated fair value.
SEHK:9969 Ownership Breakdown as at Nov 2025
Simply Wall St Growth Rating: ★★★★★☆
Overview: freee K.K. provides cloud-based accounting and HR software solutions in Japan, with a market cap of ¥214.37 billion.
Operations: The company generates revenue through its Platform Business segment, which accounted for ¥33.27 billion.
Insider Ownership: 25.4%
Earnings Growth Forecast: 38.4% p.a.
freee K.K. is experiencing significant growth, with earnings expected to increase by 38.41% annually, surpassing the Japanese market’s growth rate. Although its revenue is projected to grow at 17% per year, this lags behind its earnings expansion. The company recently became profitable and trades at a substantial discount of 46.5% below its estimated fair value. Recent board meetings have focused on share issuance and compensation plans, while net sales for fiscal year 2026 are forecasted to rise by up to 25%.
TSE:4478 Ownership Breakdown as at Nov 2025
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include SEHK:6682 SEHK:9969 and TSE:4478.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
